-

Cutera® Announces the North America Launch of xeo®+

A legacy in the aesthetics industry, xeo+ offers new and innovative features

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announces the launch of xeo+, a pioneering laser and light-based multi-application platform built on a rich history of excellence in performance and innovation. The xeo+ offers providers updated features and newly redesigned handpieces that allow for faster treatment times, optimized ease of use and an improved treatment experience.

"xeo® has played a pivotal role in the history of Cutera and I’m proud to be a part of that legacy with the launch of xeo+,” said Michael Karavitis, Ph.D., Executive Vice President, Chief Technology Officer, Cutera. “We developed an innovation inspired by the modern aesthetic practice building upon the over 20-year heritage of xeo. The new xeo+ seamlessly blends versatility and cutting-edge technology to meet the ever-evolving demands of thriving practices and we are confident that xeo+ will surpass our customers' expectations and set a new standard of excellence in the industry.”

Introduced in 2003, xeo pioneered Nd:YAG laser technology as the first 1064 nm laser with contact cooling. Its traction increased with the inclusion of the signature Laser Genesis™ treatment, an exclusive 15-minute skin revitalization treatment for all skin types that utilizes proprietary micropulses to stimulate the skin. Laser Genesis helped to raise the bar for no-downtime treatment protocols and has been widely popular amongst thousands of xeo providers and patients worldwide.

Cutera continues to set industry milestones with the modernized xeo+, designed to deliver a more streamlined approach to aesthetics with faster treatment times, an intuitive user interface and a host of features for an elevated provider and patient experience. The technology is enhanced with larger spot size options and upgraded contact cooling for improved comfort, resulting in faster Laser Genesis™ treatments and allowing practitioners to perform hair removal treatments two times faster than before. The technology also includes a versatile range of newly redesigned laser and IPL handpieces, ranging from the CoolView®, Limelight®, Prowave, and Acutip™.

“The original xeo has been a steadfast platform in my practice from the beginning,” said Dr. Mira Kaga, founder of The Kaga Institute of Medicine and Aesthetics. “The enhancements of the xeo+ have allowed me to treat faster and more efficiently, helping to streamline my operations even more and improve ROI. This technology offers a wide range of solutions and is designed to be intuitive, making it suitable for users of all experience levels.”

Addressing the most popular aesthetic concerns, xeo+ offers over 25 solutions for skin revitalization, hair removal, vascular, pigment reduction, and more. The flexibility and customization of applications allow practices the opportunity to widen their patient demographic and evolve with the demands and needs of their patients.

xeo+ is currently available to physicians throughout the US and Canada. Interested providers are encouraged to visit www.cutera.com for more information.

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. For over 25 years, Cutera has strived to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. For more information, call 1-888-4-CUTERA or visit www.cutera.com/us-en/products/xeo-plus.

Important safety and risk information about xeo+ is available by contacting Cutera at www.cutera.com/us-en/global-offices. Patients should talk to their healthcare provider.

Contacts

Media:
EvolveMKD
Cutera@EvolveMKD.com

Investor Relations:
Greg Barker, VP, Corporate FP&A, and Investor Relations
IR@Cutera.com

Cutera, Inc.

NASDAQ:CUTR
Details
Headquarters: Brisbane, CA
CEO: Taylor Harris
Employees: 450
Organization: PUB
Revenues: $252 million (2022)
Net Income: NM (2022)

Release Versions

Contacts

Media:
EvolveMKD
Cutera@EvolveMKD.com

Investor Relations:
Greg Barker, VP, Corporate FP&A, and Investor Relations
IR@Cutera.com

More News From Cutera, Inc.

Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that the Company has successfully completed its financial restructuring process and emerged from Chapter 11. Cutera emerges with a significantly stronger balance sheet, well positioned to drive innovation and growth. Through this process, Cutera has reduced its debt by nearly $400 million, or over 90%, and raised $65 million in new money financ...

Cutera Announces Voluntarily Delisting from Nasdaq

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (“Cutera” or the “Company”) (Nasdaq: CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC (“Nasdaq”) of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be...

Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that it is initiating a restructuring transaction with the support of a group of existing lenders, representing approximately 74% of the Company’s notes, to strengthen its balance sheet and position Cutera for long-term success. Through the transaction, Cutera will reduce its debt by nearly $400 million, or over 90%, and raise $65 million in ne...
Back to Newsroom